Prostatic Neoplasms D011471

Related MeSH Hierarchy (7)

Diseases [C] » Urogenital Diseases [C12] » Genital Diseases » Genital Diseases, Male » Genital Neoplasms, Male » Prostatic Neoplasms

Diseases [C] » Urogenital Diseases [C12] » Genital Diseases » Genital Diseases, Male » Prostatic Diseases » Prostatic Neoplasms

Diseases [C] » Urogenital Diseases [C12] » Male Urogenital Diseases » Genital Diseases, Male » Genital Neoplasms, Male » Prostatic Neoplasms

Diseases [C] » Urogenital Diseases [C12] » Male Urogenital Diseases » Genital Diseases, Male » Prostatic Diseases » Prostatic Neoplasms

Diseases [C] » Urogenital Diseases [C12] » Male Urogenital Diseases » Urogenital Neoplasms » Genital Neoplasms, Male » Prostatic Neoplasms

Diseases [C] » Urogenital Diseases [C12] » Urogenital Neoplasms » Genital Neoplasms, Male » Prostatic Neoplasms

Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Urogenital Neoplasms » Genital Neoplasms, Male » Prostatic Neoplasms

Description

Tumors or cancer of the PROSTATE.   MeSH

Subtype Terms (1)

Prostatic Neoplasms, Castration-Resistant
286 drugs (125 approved, 161 experimental)


Phase 3 Indicated Drugs (122)

Phase 2 Indicated Drugs (379)

103-palladium

111in-j591

131i-psma-1095

13c-pyruvate

177lu-dota-tlx591

177lu-psma-i&t

18f-naf

2-hydroxyflutamide

68ga-nota-ae105

68ganota-anti-her2 vhh1

68ga−psma−hbed−cc

89zr df-iab2m

89zr-df-iab2m

99mtc psma

abemaciclib (verzenio)

acai polyphenolics

acetogenins

acetylcarnitine

ad5-ycd/muttksr39rep-adp

adavosertib

adenoviral vector expressing hsv-tk

afatinib (gilotrif)

aldesleukin (proleukin)

alisertib

allogeneic tumor cell vaccine

alprostadil (prostin)

alvocidib

amg-208

amifostine (ethyol)

aminoglutethimide (cytadren)

anastrozole (arimidex)

antineoplaston a10

apatorsen

ard6562

arginine

arsenic trioxide (trisenox)

avelumab (bavencio)

axitinib (inlyta)

azacitidine (vidaza)

azd-4547

azd4635

azd5312

azd-5672

azd6738

bay86-7548

berzosertib

bi-2536

binimetinib (mektovi)

bortezomib (velcade)

bromelains

bryostatin

buparlisib

c11-sodium acetate

calcifediol

camellia sinensis extract

capecitabine (xeloda)

capromab pendetide (Prostascint)

capsaicin (qutenza)

carlumab

carmustine (bicnu)

carotenoids

carotuximab

carvedilol (coreg)

cediranib

cep-11981

cetrelimab

cetuximab (erbitux)

cfi-400945

cgc-11047

chir-258

cholesterol

cinacalcet (sensipar)

cixutumumab

colchicine (colbenemid)

conjugated equine estrogens

cotrimoxazole

cranberry

crizotinib (xalkori)

ct-2584

cv301

cv9104

cyanocobalamin (berocca)

cytarabine (cytosar-u)

dabrafenib (tafinlar)

daratumumab (darzalex)

dc1 vaccine

decaffeinated black tea

decitabine (dacogen)

defactinib

dendritic cells dcvac/pca

desogestrel (Mercilon)

diclofenac (voltaren)

digoxin (lanoxin)

diindolylmethane

dolastatin

dovitinib

doxercalciferol (hectorol)

dupilumab (dupixent)

durvalumab (imfinzi)

efavirenz (sustiva)

eflornithine (ornidyl)

enzastaurin

ephb4-hsa fusion protein

epirubicin (ellence)

epothilone

erdafitinib (Balversa)

eribulin (halaven)

erlotinib (tarceva)

esk981

estetrol

etaracizumab (abegrin)

etodolac (lodine)

exatecan mesylate

exemestane (aromasin)

ferumoxytol (feraheme)

figitumumab

fish oil (Omegavan)

flaxseed

flibanserin (addyi)

fluoromisonidazole

fluvastatin (lescol)

folic acid

fowlpox-prostate specific antigen vaccine

fowlpox virus vaccine

fulvestrant (faslodex)

ga 68 dota-neobomb1

gadobenate (multihance)

gadolinium

gadoxetate disodium (eovist)

gallium-68-dotatate (netspot)

galunisertib

ganetespib

ge-148

gefitinib (iressa)

gosspyl acetate

gpi 1485

grape seed extract

gsk-2636771

gti-2040

gtx-758

gv 1001

gvax pancreatic cancer vaccine

gx301

her2bi-armed activated t cells

human fecal microbiota

humax-il8

hx4

hydroxychloroquine (plaquenil)

icosapent ethyl (vascepa)

il-7

imatinib (gleevec)

imp4297

inactivated influenza vaccine

incomplete freund's adjuvant

indomethacin (indocin)

interferon alpha-2b (Intron-A)

interleukin-12

intetumumab

ipatasertib

isotretinoin (accutane)

ispinesib

it-101

itraconazole (sporanox)

ixabepilone (ixempra)

kanglaite

kos862

ladiratuzumab vedotin

lapatinib (tykerb)

larotrectinib (vitrakvi)

lestaurtinib

leuvectin

l-glutamine

licorice root extract

linsitinib

litgenprostucel-l

litronesib

lovastatin (mevacor)

lu177 monoclonal antibody j591

ly2181308

ly-2452473

masoprocol (actinex)

melphalan (alkeran)

memantine (namenda)

me tarp vaccine

metformin (glucophage)

methylphenidate (ritalin)

metilcelulosa

metronidazole (flagyl)

mgi-114

mifepristone (mifeprex)

milk protein

mipsagargin

mk-1775

mrna from psa, pap, survivin and htert transfected dendritic cell

msb0011359c

msk-2206

multi-valent pneumococcal conjugate vaccine

mva.5t4

mva-bn-brachyury

mva-muc1-il2

myeloid dendritic cells

n-(4-hydroxyphenyl)all-trans retinamide

n-acetyl-s-(1,2-dichlorovinyl)-l-cysteine

naltrexone (revia)

naproxen (naprosyn)

navitoclax

nebentan

nedisertib

neratinib maleate (nerlynx)

nexrutine

niclosamide (nicloside)

nintedanib (ofev)

niraparib (zejula)

noni extract

oblimersen sodium

olaratumab (lartruvo)

oleclumab

omeprazole (prilosec)

oncoxin-viusid

ony-p1

opaganib

orca-010

osi-461

osimertinib (tagrisso)

oxaliplatin (eloxatin)

oxybutynin (ditropan)

ozarelix

pacritinib

palbociclib (ibrance)

panitumumab (vectibix)

panobinostat (farydak)

pantoprazole (protonix)

papain

papaverine

paricalcitol (zemplar)

pazopanib (votrient)

pegylated carboxyhemoglobin

pemetrexed (alimta)

perflutren protein-type a microspheres (Optison)

perifosine

perillyl alcohol

peripheral blood hematopoietic cell

pertuzumab (perjeta)

pexidartinib (Turallo)

pf-04518600

phenelzine (nardil)

phenoxodiol

phentolamine mesylate (regitine)

phenylacetic acid (ucephan)

phenylacetylgluatmine

pi-88

pidilizumab

pimonidazole

piperine

plasmacytoid dendritic cells

plitidepsium

polyethylene glycol 3350 (colyte)

pomalidomide (pomalyst)

pomegranate

pomegranate extract

pomegranate juice

pracinostat

prednisolone (hydeltra)

prevastein hc

prexasertib

propranolol (inderal)

proscavax

prostate specific membrane antigen

prostatic acid phosphatase-sargramostim fusion protein

prostvac-v/tricom

psa:154-163 peptide vaccine

psa prostate cancer vaccine

ptvg-ar

ptvg-hp

ptvg-hp plasmid dna vaccine

pyridoxine

quercetin

quinacrine

raloxifene (evista)

ramucirumab (cyramza)

rebimastat

recombinant human choriogonadotropin alfa (Ovidrel)

rf-psa

ribociclib (kisqali)

ridaforolimus

Phase 1 Indicated Drugs (211)


Organization Involved with Phase 3 Indications (291)

21st Century Oncology

Abbott

AB Science

ABX advanced biochemical compounds GmbH

ABX-CRO advanced pharmaceutical services Forschungsgesellschaft m.b.H.

Academic and Community Cancer Research United

Accord Research

Active Biotech AB

Advanced Nuclear Medicine Ingredients

Agennix

Agouron

Akron City Hospital

Alliance Foundation Trials

American College of Radiology

Amgen

Amitabha Medical Clinic and Healing Center

Aragon Pharmaceuticals

Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie (ARTIC)

Auron Healthcare GmbH

Austin Health

Australian and New Zealand Urogenital and Prostate Cancer Trials Group

Australian National University

Aventis

Badalona Hospital Germans Trias i Pujol

Barr Laboratories

Barts & The London NHS Trust

Bausch Health Companies

Bavarian Nordic

b.e.imaging GmbH

Biologics, Inc.

Bon Secours Cancer Institute

Bracco

Bristol-Myers Squibb

British Columbia Cancer Agency

BSM Diagnostica GmbH

Canadian Cancer Trials Group

Canadian Institutes of Health Research (CIHR)

Canadian Urologic Oncology Group

Cancer and Leukemia Group B (CALGB)

Cancer Research UK

Cancer Society of New Zealand

Cancer Trials Ireland

Candel Therapeutics

Cantonal Hospital of St. Gallen

Cantonal Hospital Winterthur

Carolina Urologic Research Center

Case Western Reserve University

Cayetano Heredia University

Cedars-Sinai Medical Center

Celgene

Cell Genesys

Center Eugene Marquis

Central European Cooperative Oncology Group

Centre Catherine de Sienne - Nantes

Centre de Recherche Clinique du CHUS

Centre Georges Francois Leclerc

Centre Henri Becquerel

Centre hospitalier de Mulhouse

Centre Hospitalier de Saint-Brieuc

Centre Jean Perrin

Centre Leon Berard

Charing Cross Hospital

Chinese University of Hong Kong

Churchill Pharmaceutical LLC

Clinique Pasteur

Clovis Oncology

CMX Research

Columbia University

Contura

Cornell University

Corporacion Parc Tauli

Cougar Biotechnology

CSSS Champlain - Charles-Lemoyne Hospital

Curie Institute

Deaconess Medical Center, Spokane, Washington

Decatur Memorial Hospital

Dendreon

Department of Veteran Affairs

Duke University

Eastern Cooperative Oncology Group

Eastern Health, Canada

ECOG-ACRIN Cancer Research Group

EcoNugenics

Emerson Hospital, Concord, MA

Emory University

Endocyte

Endo Pharmaceuticals

Erasmus University Rotterdam

Eurofarma Laboratorios S.A.

European Organisation for Research and Treatment of Cancer

Exelixis

Fimlab laboratories

Fondazione Giovanni Pascale

Foresee Pharmaceuticals Co., Ltd.

Foundation Medicine

Free University of Amsterdam

Fudan University

Fundación Althaia Manresa

Goeteborgs Universitet

Government of Finland

GPC Biotech Inc.

GP-Pharm

Grenoble Alps University

Groupe Hospitalier Paris Saint Joseph

GTx

GU Research Network, LLC

Haisco Pharmaceutical

Harvard University

Health Research Council, New Zealand

Hengrui Therapeutics, Inc.

Herbert Irving Comprehensive Cancer Center

Hinova Pharmaceuticals, Inc.

Hoosier Cancer Research Network

Hospital General Tlahuac

Hospital San Giacomo of Novi Ligure

Hospital Universitario Lucus Augusti

Humboldt University

Icahn School of Medicine at Mount Sinai

IND 2 Results LLC

Indiana University

Innovate UK

Institut Bergonié

Institut de Cancérologie de Lorraine

Institut de Cancerologie de l'Ouest Paul Papin

Institut Gustave Roussy

Institut Paoli-Calmettes

IQVIA

Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd

Johns Hopkins University

Kantonsspital Graubünden

Karolinska Institute

Katholieke Universiteit Leuven

Kaunas University

Kuopio University Hospital

Kyoto University

L'Institut Mutualiste Montsouris-Paris

Louisiana State University

Lowell General Hospital

Lund University

Luye Pharma

Maastricht University

Maitland Cancer Appeal

MANA RBM

Marmara University

McGill University

McMaster University

Medical College of Georgia

Medical College of Wisconsin

Medical Research Council

Medicine Invention Design, Inc

Memorial Sloan-Kettering Cancer Center

Michael Reese Hospital and Medical Center

Millennium Pharmaceuticals

Molecular Insight Pharmaceuticals

Myovant Sciences GmbH

National Cancer Institute, France

National Health and Medical Research Council, Australia

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Netherlands Cancer Institute

Newcastle University

New Mexico Cancer Care Alliance

New York Prostate Institute

North Central Cancer Treatment Group

Northwest Biotherapeutics

Novacea

Novus Pharma

NRG Oncology

Oakwood Laboratories, LLC

OncoGenex Technologies

Orebro University

Oregon Health and Science University

Orion Corporation

Pan-American Medical Research Institute

Parexel

Peter MacCallum Cancer Centre

Pfizer

Polyclinique d'oncologie de Gentilly, Nancy, France

PPD

Progenics

Prostate Cancer Canada Network

Proton Collaborative Group

QPS

Radiation Therapy Oncology Group

Radiological Associates of Sacramento Medical Group at Sutter Cancer Center

Regeneron

Roche

Royal Marsden Hospital NHS Trust

Saint Anne's Hospital

Sanchez Cancer Center

Saving Patients' Lives Medical B.V.

Scandinavian Prostate Cancer Group

Schiffler Cancer Center

Seattle Prostate Institute

Siemens

Southwest Oncology Group

Spanish Oncology Genito-Urinary Group

Stanford University

State University of New York, Buffalo

St. Luke's Hospital, Ireland

St. Luke's-Roosevelt Hospital Center

Sugen

Swiss Group for Clinical Cancer Research

Syne Qua Non Limited

Syntax for Science

Takeda

Technical University of Dresden

Temple University

Teva

The Swedish Research Council

The University of Texas, Dallas

Thomas Jefferson University

Tianjin Medical University

Tianjin University of Traditional Chinese Medicine

Translational Research Informatics Center, Kobe, Hyogo, Japan

Trans Tasman Radiation Oncology Group

Tulane University

UNICANCER

United States Army

United States Navy

Universidad Autonoma de Barcelona

Universidad Complutense de Madrid

Universidad de Cordoba

Université catholique de Louvain

University of Alberta

University of Amsterdam

University of Arizona

University of Barcelona

University of Birmingham

University of Bristol

University of British Columbia

University of Calgary

University of California, Davis

University of California, Los Angeles

University of California, San Francisco

University of Colorado, Denver

University of Coruna

University of Freiburg

University of Goettingen

University of Gothenburg

University of Grenoble

University of Groningen

University of Helsinki

University of Illinois at Chicago

University of Iowa

University of L'Aquila

University of Limoges

University of Lorraine

University of Lyon

University of Malaga

University of Maryland

University of Miami

University of Michigan

University of Milan

University of Minnesota

University of Montpellier

University of Montreal

University of New Mexico

University of North Carolina, Charlotte

University of Oxford

University of Paris

University of Pennsylvania

University of Pisa

University of Pittsburgh

University of Poitiers

University of Reims

University of Rennes

University of Salamanca

University of Saskatchewan

University of Seville

University of Sherbrooke

University of Southern California

University of South Florida

University of Strasbourg

University of Sydney

University of Tartu

University of Toulouse

University of Turin

University of Turku

University of Ulm

University of Utah

University of Vienna

University of Washington

University of Wisconsin

Urology San Antonio Research PA

Velindre NHS Trust

Wake Forest University

Washington University in St. Louis

Wayne State University

Wheeling Hospital

Yale University

Zevacor

Organization Involved with Phase 2 Indications (411)

AbbVie

Abgenix

ABX-CRO

Adamis Pharmaceuticals Corporation

Advanced Accelerator Applications

Advaxis, Inc.

AEterna Zentaris

Aga Khan University

Alberta Cancer Foundation

Alexandra Hospital, Athens, Greece

All-Russia Centre for Urgent Care and Radiation Medicine

American Cancer Society, Inc.

American Society of Clinical Oncology

Amersham

Antisoma Research

Arcus Biosciences, Inc.

Ariad Pharmaceuticals

Arizona Oncology Services

Arno Therapeutics

Ascenta Therapeutics

Assistance Publique - Hôpitaux de Paris

Association of Urogenital Oncology (AUO)

Astex Pharmaceuticals, Inc.

Athenex, Inc.

Attenuon

Augusta University

Australasian Radiopharmaceutical Trials network

Australian Nuclear Science and Technology Organisation

Avid Bioservices

Azienda Ospedaliera San Camillo Forlanini

Bajcsy-Zsilinszky Hospital

Baylor University

Behnam Daheshpour Charity Organization, Tehran

BeiGene

Besins Healthcare

BIND Therapeutics

Biontech

BioXcel Therapeutics Inc

Boehringer Ingelheim

Boston University

Bostwick Laboratories

Broad Institute

Brown University

Buckinghamshire Healthcare NHS Trust

Burzynski Research Institute

BZL Biologics

Cadila Healthcare

California Walnut Commission

Camurus AB

Canadian Cancer Clinical Trials Network

Canadian Cancer Society

Cancer Immunotherapy Trials Network

Cancer Research Antwerp

Cancer Therapeutics Research Group

Capcure

Cardiff Oncology

Carolina Research Professionals, LLC

Cascadian Therapeutics Inc.

CASI Pharmaceuticals, Inc.

Catalysis SL

CellCentric Ltd.

Cellular Biomedicine Group Ltd.

Centocor

Central European Society for Anticancer Drug Research (CESAR)

Central South University

Centre for Probe Development and Commercialization

Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer

Cephalon

Changhai Hospital

Chao Family Comprehensive Cancer Center

Charles University

Chatrapati Sahuji Mahraj Medical University

Chinese Academy of Medical Sciences

Choithram Hospital and Research Centre

Christian Medical College, Vellore, India

CHU Mont-Godinne

City Clinical Hospital # 57

City of Hope National Medical Center

Cleveland BioLabs

Cognis

Colchester Hospital University NHS Foundation Trust

Comprehensive Cancer Centers of Nevada

Constellation Pharmaceuticals

Corcept Therapeutics

Cortice Biosciences, Inc.

CTI BioPharma

CureVac AG

Cytogen

Cyto Pulse Sciences, Inc.

CytRx

Daiichi Sankyo

Dalhousie University

DanTrials ApS, Copenhagen, Denmark

Dartford and Gravesham NHS Foundation Trust

Department of Defense

Desert Regional Comprehensive Cancer Center

Devine Tidewater Urology

DexTech Medical AB

Dong-A Pharmaceutical

Duramed Research

East and North Hertfordshire NHS Trust

Eastchester Center for Cancer Care

Effector Therapeutics

E-Group ICT Software Informatikai Zrt.

Eisai

E.J. Whitten Foundation Prostate Cancer Research Centre

Eli Lilly

ESSA Pharmaceuticals

European Research Council

Excel Diagnostics and Nuclear Oncology Center

Finnish Cultural Foundation

Fordham University

Free University of Brussels

Frimley Park Hospital NHS Trust

Fundación Canaria de Investigación Sanitaria

Fundación de investigación HM

Genentech

General Electric

Genmab

GenomeDx Biosciences Corp

Genta

Genzyme

Georgetown University

German Cancer Research Center

Ghent University

Gilead Sciences

GIRCI (French Interregional Group of Clinical Research and Innovation)

Gloucester Pharmaceuticals

Government of Australia

Government of Canada

Government of Norway

Government of Russia

Government of Taiwan

Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)

Groupe D'Etude des Tumeurs Uro-Genitales

Guangdong Pharmaceutical University

Guangdong Provincial Hospital of Traditional Chinese Medicine

Guangzhou University

H2O Clinical LLC

Hamilton Health Sciences Corporation

Harbor Therapeutics

Health Ever Bio-Tech Co., Ltd.

Heatherwood and Wexham Park Hospitals NHS Foundation Trust

Hebrew University

Hellenic Cooperative Oncology Group

HemaCare Corporation

Hemispherx Biopharma

Henry Ford Health System

High Impact Clinical Research Support Program

Hoag Memorial Hospital Presbyterian

Hope Cancer Institute, Inc.

Hospital Moinhos de Vento

Hospital Sirio-Libanes

Howard University

Illinois CancerCare, P.C.

ImaginAb, Inc.

Imclone

Immetacyte

Immunex

Immunomedics

Immunovative Therapies

Incyte

Infinity Pharmaceuticals, Inc.

Innocrin Pharmaceutical

Inova Health System

Insmed, Inc.

Inspyr Therapeutics, Inc.

Institut Mutualiste Montsouris

Instituto do Cancer do Estado de São Paulo

Insys Therapeutics Inc

Ionis Pharmaceuticals, Inc.

Io Therapeutics

Istituto Nazionale per lo Studio e la Cura dei Tumori

Italian Trial in Medical Oncology

Iwate Medical University

Jahn Ferenc South Pest Hospital

James Graham Brown Cancer Center

Jiao Tong University

Jinan University

Kael-GemVax Co., Ltd.

Kaiser Permanente

Karyopharm Therapeutics Inc

Kasturba Medical College

Kidwai Memorial Institute of Oncology, Bangalore

Klus Pharma Inc.

Korea University

Laboratoires Leurquin Mediolanum

Laekna Limited

Latin American Cooperative Oncology Group

Laval University

Leap Therapeutics, Inc.

Leiden University

Lidds AB

Ligue Contre le Cancer (French association Against Cancer)

LTMMC & LTMGH

Macquarie University

Madison Vaccines Incorporated

Maidstone & Tunbridge Wells NHS Trust

Mansoura University

Medical Research Future Fund (MRFF)

Medical University of South Carolina

Medical University of Vienna

MedImmune

MedSIR

MedSource

Medway NHS Foundation Trust

MEI Pharma

Merck KGaA

Merrion Pharmaceuticals, LLC

Methodist Cancer Center, Houston, Texas

Michigan State University

Modra Pharmaceuticals

Momotaro-Gene Inc.

Moorgreen Hospital, Southampton

Morton Plant Mease Health Care

Moscow Oncology Research Institute

Movember Foundation

Myrexis Inc.

Nanjing Medical University

Nanjing University

NanOlogy, LLC

National Cancer Center, Korea

National Center for Complementary and Integrative Health (NCCIH)

National Comprehensive Cancer Network

National Health Service, United Kingdom

National Institute of Nursing Research (NINR)

National Institute on Aging (NIA)

National University of Ireland

National University of Singapore

Nerviano Medical Sciences

NewLink Genetics Inc

New York University

Nihon Medi Physics

Northern Sydney and Central Coast Area Health Service

North Middlesex University Hospital NHS Trust

Northwell Health

Norwegian Cancer Society

Nymox Corporation

OBI Pharma, Inc

Ohio State University

OHSU Knight Cancer Institute

OncBioMune, LLC

Oncology Specialists, S.C.

Oncology Venture

Oncolytics Biotech

Oncotech

Optimal Health Research

Orca Therapeutics B.V.

Ortho Biotech, Inc.

Osaka City University

Osaka University

OSI Pharmaceuticals

Ospedale Beata Vergine

Otsuka

Oxford BioMedica

Ozmosis Research Inc.

Pacific-Link Consulting

Pacific Northwest SPORE

Palacky University

Panacela Labs LLC

Pantarhei Bioscience

Paris Descartes University

Patel Hospital Pvt. Ltd.

Peachtree Hematology Oncology Consultants

Pepscan Therapeutics

Peterfy Sandor Street Hospital

PharmaMar

Phoenix Molecular Imaging

Piramal

Pivotal S.L.

Plexxikon

Polyphenon Pharma

POM Wonderful LLC

Poniard Pharmaceuticals

Postgraduate Institute of Medical Education and Research

Progen Pharmaceuticals

Prologue Research International

Prostaatkankerstichting

Prostate Cancer Clinical Trials Consortium

Prostate Cancer Foundation

Prostate Cancer Foundation Norway

Prostate Cancer Foundation of Australia

Prostate Cancer Research Alliance

Prostate Cancer UK

Prostate Institute of America

Providence Health & Services

Qingfeng Pharmaceutical Group

Radio Isotope Therapy of America

RadioMedix

Rajiv Gandhi University of Health Sciences

Rampart Health, L.L.C.

RCC, Trivandrum

Research Institute of Oncology n.a. Professor N.N. Petrov under the Federal Agency for Healthcare and Social Development

Rhode Island Hospital

RhoVac

RITA Foundation

Rockefeller University

RTOG Foundation

Russian Academy of Medical Sciences

Rutgers University

Saarland University

Safdarjang Hospital

SCRI Development Innovations

Seattle Genetics

Seinajoki Central Hospital

Seoul National University

Seth Gordhandas Sunderdas Medical College

Shahid Beheshti University of Medical Sciences

Shanghai Bioray Laboratory Inc.

Singapore General Hospital

SLS Oncology, LLC

Smerud Medical Research Denmark

Solvay

Sophiris Bio Corp

Southend University Hospital Foundation NHS Trust

Spectrum Pharmaceuticals

Sponsor GmbH

St. Barnabas Medical Center, Livingston, NJ

St. Petersburg State Public Medical Institution

St. Vincent's Hospital-Manhattan

Sungkyunkwan University

Sun Pharmaceuticals

Suzhou Kintor Pharmaceutical Inc,

Sydney Haematology and Oncology Clinics

Symphony Capital

Taiwan Cooperative Oncology Group

TFS Trial Form Support

The Adelaide and Meath Hospital

The European Uro-Oncology Group

The Prostate Cancer Research Foundation of Canada

The Queen's Medical Center

Theradex

Theragnostics Ltd

Therion Biologics Corporation

The University of Texas Health Science Center, Houston

The Wayne D. Kuni and Joan E. Kuni Foundation

Thomayer's Hospital

Tiltan Pharma

Titan Pharmaceuticals

Tracon Pharmaceuticals Inc.

Transgene

Translational Oncology Research International

Tyme, Inc

Ultimovacs AS

Universidad Autonoma de Madrid

Universidad Carlos III Madrid

University of Adelaide

University of Alabama, Birmingham

University of Antwerp

University of Bern

University of Bordeaux

University of Caen-Normandie

University of California, Irvine

University of California, San Diego

University of Cambridge

University of Central Florida

University of Chicago

University of Eastern Finland

University of Erlangen-Nuremberg

University of Florida

University of Genoa

University of Hamburg

University of Havana

University of Hawaii

University of Heidelberg

University of Ioannina

University of Kansas

University of Kentucky

University of Las Palmas de Gran Canaria

University of Liverpool

University of Medicine and Dentistry of New Jersey

University of Munster

University of Naples Frederico II

University of Nebraska

University of New South Wales

University of Nice Sophia Antipolis

University of North Carolina at Chapel Hill

University of Nottingham

University of Oslo

University of Pecs

University of Pilsen

University of Quebec

University of South Carolina

University of Technology, Sydney

University of Tokyo

University of Ulsan

University of Valencia

Uppsala University

US Biotest

US Oncology

Vaccitech Limited

ValiRx

Vasgene Therapeutics, Inc

Veeda Clinical Research

Veru Inc.

Vical

Vicus Therapeutics

Vion Pharmaceuticals

Virginia Commonwealth University

Virginia Mason Medical Center

Virginia Oncology Associates

Vita-Salute University of Milano. Italy

Wentworth-Douglass Hospital

Whittingham Cancer Center

Winthrop University

Wroclaw Medical University

Wyeth

Xanthus Pharmaceuticals, Inc.

Yeshiva University

Zenith Epigenetics

Zhejiang Kanglaite Pharmaceutical Co.Ltd

Organization Involved with Phase 1 Indications (120)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.